Search research articles
Contact Us
Filters
Showing results (11-20 of 51) with videos related to
Page
of 6
Sort By:
Immunotherapy
|
November 22, 2021
Can we identify a preferred first-line strategy for sarcomatoid renal cell carcinoma? A network meta-analysis
Sebastiano Buti, Melissa Bersanelli, Giulia Mazzaschi, et al.
Cancers
|
September 25, 2019
Current Treatment Options for Metastatic Hormone-Sensitive Prostate Cancer
Carlo Cattrini, Elena Castro, Rebeca Lozano, et al.
Translational Oncology
|
May 17, 2020
Integrative Analysis of Periostin in Primary and Advanced Prostate Cancer
Carlo Cattrini, Paola Barboro, Alessandra Rubagotti, et al.
Anti-Cancer Drugs
|
July 12, 2016
Genitourinary tumours in the targeted therapies era: new advances in clinical practice and future perspectives
Carlo Messina, Giulia Buzzatti, Chiara Dellepiane, et al.
Breast Cancer Research and Treatment
|
July 29, 2018
CDK4/6 inhibitors in advanced hormone receptor-positive/HER2-negative breast cancer: a systematic review and meta-analysis of randomized trials
Carlo Messina, Carlo Cattrini, Giulia Buzzatti, et al.
Anti-Cancer Drugs
|
May 17, 2016
Immunotherapy for genitourinary cancer: state of the art and new perspectives
Carlo Cattrini, Chiara Dellepiane, Alessia Cavo, et al.
Cancers
|
April 12, 2022
Apalutamide, Darolutamide and Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC): A Critical Review
Carlo Cattrini, Orazio Caffo, Ugo De Giorgi, et al.
Cancers
|
September 22, 2019
Role of Circulating Tumor Cells (CTC), Androgen Receptor Full Length (AR-FL) and Androgen Receptor Splice Variant 7 (AR-V7) in a Prospective Cohort of Castration-Resistant Metastatic Prostate Cancer Patients
Carlo Cattrini, Alessandra Rubagotti, Linda Zinoli, et al.
Cancers
|
September 28, 2021
Optimal Sequencing and Predictive Biomarkers in Patients with Advanced Prostate Cancer
Carlo Cattrini, Rodrigo España, Alessia Mennitto, et al.
Therapeutic Advances in Urology
|
July 22, 2021
Antiangiogenic tyrosine kinase inhibitors and immunotherapy as first-line treatment for metastatic renal cell carcinoma: is there an increased risk of hypothyroidism?
Giandomenico Roviello, Sebastiano Buti, Carlo Cattrini, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 51) with videos related to
Sort By:
Page
of 6
Immunotherapy
|
November 22, 2021
Can we identify a preferred first-line strategy for sarcomatoid renal cell carcinoma? A network meta-analysis
Sebastiano Buti, Melissa Bersanelli, Giulia Mazzaschi, et al.
Cancers
|
September 25, 2019
Current Treatment Options for Metastatic Hormone-Sensitive Prostate Cancer
Carlo Cattrini, Elena Castro, Rebeca Lozano, et al.
Translational Oncology
|
May 17, 2020
Integrative Analysis of Periostin in Primary and Advanced Prostate Cancer
Carlo Cattrini, Paola Barboro, Alessandra Rubagotti, et al.
Anti-Cancer Drugs
|
July 12, 2016
Genitourinary tumours in the targeted therapies era: new advances in clinical practice and future perspectives
Carlo Messina, Giulia Buzzatti, Chiara Dellepiane, et al.
Breast Cancer Research and Treatment
|
July 29, 2018
CDK4/6 inhibitors in advanced hormone receptor-positive/HER2-negative breast cancer: a systematic review and meta-analysis of randomized trials
Carlo Messina, Carlo Cattrini, Giulia Buzzatti, et al.
Anti-Cancer Drugs
|
May 17, 2016
Immunotherapy for genitourinary cancer: state of the art and new perspectives
Carlo Cattrini, Chiara Dellepiane, Alessia Cavo, et al.
Cancers
|
April 12, 2022
Apalutamide, Darolutamide and Enzalutamide for Nonmetastatic Castration-Resistant Prostate Cancer (nmCRPC): A Critical Review
Carlo Cattrini, Orazio Caffo, Ugo De Giorgi, et al.
Cancers
|
September 22, 2019
Role of Circulating Tumor Cells (CTC), Androgen Receptor Full Length (AR-FL) and Androgen Receptor Splice Variant 7 (AR-V7) in a Prospective Cohort of Castration-Resistant Metastatic Prostate Cancer Patients
Carlo Cattrini, Alessandra Rubagotti, Linda Zinoli, et al.
Cancers
|
September 28, 2021
Optimal Sequencing and Predictive Biomarkers in Patients with Advanced Prostate Cancer
Carlo Cattrini, Rodrigo España, Alessia Mennitto, et al.
Therapeutic Advances in Urology
|
July 22, 2021
Antiangiogenic tyrosine kinase inhibitors and immunotherapy as first-line treatment for metastatic renal cell carcinoma: is there an increased risk of hypothyroidism?
Giandomenico Roviello, Sebastiano Buti, Carlo Cattrini, et al.
Page
of 6